Results 251 to 260 of about 37,295 (269)
Some of the next articles are maybe not open access.

Standards for Levothyroxine Preparations

JAMA: The Journal of the American Medical Association, 1980
To the Editor.— Jacobson and coworkers (243:733, 1980) recently presented their experience on the nonequality of two thyroxine preparations. They demonstrated that the 100-μg tablets from Letter and Synthroid were physiologically nonbioequivalent and therefore should not be dispensed interchangeably.
Arvin P. Shroff, Judith K. Jones
openaire   +2 more sources

Error in Dose of Levothyroxine

JAMA, 1978
To the Editor.— We were surprised to read in the QUESTIONS AND ANSWERS section (239:1205-1208, 1978) that the patient who had surgery for an autonomous hot thyroid nodule subsequently was treated with levothyroxine sodium (Synthroid), 0.5 mg/day. Our experience is consistent with Stock et al 1 and Cotton et al 2 in suggesting that the vast majority of
openaire   +3 more sources

Levothyroxine Prescription

JAMA, 2014
Importance Rates of thyroid hormone prescribing in the United States and the United Kingdom have increased substantially. If some of the increase is due to lowering the thyrotropin threshold for treatment, this may result in less benefit and greater harm.
openaire   +3 more sources

Interference with the absorption of levothyroxine

Current Opinion in Endocrinology & Diabetes, 2003
Levothyroxine sodium is commonly prescribed for physiologic replacement of hypothyroidism and suppression of thyroid neoplasia. The absorption of levothyroxine (L-T4) is approximately 80% after oral administration. Gastrointestinal diseases may cause malabsorption, and certain drugs have been shown to interfere with the absorption of L-T4.
Jerome M. Hershman, Nalini Singh
openaire   +2 more sources

In Vivo Comparison of Levothyroxine Preparations

JAMA: The Journal of the American Medical Association, 1982
Two brands of levothyroxine sodium (Levothroid and Synthroid) were found not to be bioequivalents. Until a more precise standardization for levothyroxine sodium preparation is available, patients should be consistently treated with one brand name preparation.
Robert L. Young   +2 more
openaire   +3 more sources

[unk] (Levothyroxine)-Reply

JAMA: The Journal of the American Medical Association, 1992
In Reply. — JAMA reaches a wide range of Chinese-speaking medical and health care specialists all over the world. There are over 1.25 billion Chinese-speaking people and not many of them have full command of the medical specialty involved, nor are there too many of them who have the expertise to select an appropriate Chinese term for levothyroxine ...
openaire   +2 more sources

Substitution of Levothyroxine Products

JAMA: The Journal of the American Medical Association, 1979
ABSTRACT To the Editor.— Since calling attention to the problem of generic substitution of levothyroxine products in a recent letter (240:1241, 1978), we recently encountered evidence demonstrating that in one case, a generic product was not equal in potency to the brand name product.A 68-year-old woman who had primary hypothyroidism and a large goiter
openaire   +2 more sources

The emergence of levothyroxine as a treatment for hypothyroidism

Endocrine, 2016
To describe the historical refinements, understanding of physiology and clinical outcomes observed with thyroid hormone replacement strategies.A Medline search was initiated using the search terms, levothyroxine, thyroid hormone history, levothyroxine mono therapy, thyroid hormone replacement, combination LT4 therapy, levothyroxine Bioequivalence ...
openaire   +3 more sources

Treatment of Hypothyroidism with Levothyroxine

New England Journal of Medicine, 1987
A.G.H. Smals   +3 more
openaire   +3 more sources

The Nonequivalence of Levothyroxine Products

Drug Intelligence & Clinical Pharmacy, 1986
Betty J. Dong   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy